The Research & Technology Series


 London Heathrow Marriott Hotel | Thursday 10th October & Friday 11 October 2019

Track Switch 

Listen to any talk. You are free to move between all five congresses

Leading Sponsors

Diamond Sponsor

Platinum Sponsor

Platinum Sponsor

Discover how you can be a part of this meeting.

Email: [email protected]

Gold Sponsor

Gold Sponsor

Gold Sponsor

Keynote Speakers Include


Senior Research Fellow, King’s College London

T4 Pan-ERB-Targeted CAR T-Cell Immunotherapy of Head and Neck Cancer: Phase I Trial Results


CSO, Imcheck Therapeutics

Development of a next generation immune checkpoint modulator towards the clinic; a humanized BTN3A antibody (ICT01) activating gamm9delta2 T cells


Director of the Flow Cytometry Facility, University of Lausanne

Imaging Flow Cytometry – combining statistically powerful flow cytometry with information rich microscopy


Established Chair, Biomedical Sciences, University of Bradford

A Liquid Biopsy Assay to detect Cancer


Head, Department of Drug Development and Innovation (D3i), Institut Curie

Optimising patient benefit whilst reducing toxicity risk

About the Event

Immuno-oncology has already established itself as a vital weapon in the fight against cancer, and with a market value expected to reach $125 billion by 2024, it continues to revolutionize patient care.

The Research & Technology Series: Immuno-oncology is a multi-event forum for exploring the latest developments in key areas of immuno-oncology. It will bring together 250 industry and academic leaders at the cutting edge of research and provides you with an opportunity to make connections with industry experts, researchers, investors and businesses in your field.

100 individual presentations will be given across the five meetings. Talks will look to cover the potential of predictive biomarkers such as the tumour mutation burden to enhance personalised care, and new biomarker and antigen discovery, as well as the development of novel large molecule immunotherapies including new antibody formats and T cell therapeutics.

How You Will Benefit

  • Keynote speakers from organisations including: AstraZeneca, Boehringer-Ingelheim, GSK, MedImmune, and Merck KGaA
  • Discover the latest research emanating from leading universities including the J. Craig Venter Institute, Institut Curie, King’s College London and University of Lausanne
  • Extended discussion of issues such as: Next-Generation Antibodies:beyond bispecifics and Translating liquid biopsies into routine care.
  • "Track-hop" across all the co-located meetings
  • 100+ presentations from though leaders
  • Showcase your own research in a dedicated poster session
  • 7+ hours of networking time including a drinks reception offering an outstanding forum in which to forge new collaborations to better translate your research.
  • Meet over 30 solution providers and explore new products and services

Poster Presentations

Poster presentation sessions will take place in breaks and alongside the other breakout sessions of the conference. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.

We also issue a poster eBook to all attendees with your full abstract in and can share your poster as a PDF after the meeting if you desire (optional).

Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.

In order to present a poster at the forum you need to be registered as a delegate. Please note that there is limited space available and poster space is assigned on a first come first served basis (subject to checks and successful registration).

Admin fee: £100. This fee is waived for those representing academic institutions and not for profit organisations.

Submission instructions

We will require the form (downloadable below) to be submitted by the 20th September. This is the formal deadline however space is another limiting factor so early application is recommended. Therefore please contact us with any questions you have as soon as possible